Vanguard Group Inc Pet Vivo Holdings, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.6 - $2.18 $103,920 - $377,576	-173,200 Reduced 74.32%	59,855 $63,000
Q1 2023 May 15, 2023	BUY	$2.2 - $3.4 $14,960 - $23,120	6,800 Added 3.01%	233,055 $640,000
Q4 2022 Feb 10, 2023	BUY	$1.85 - $2.69 $218 - $317	118 Added 0.05%	226,255 $443,000
Q1 2022 May 13, 2022	BUY	$1.25 - $3.97 $14,063 - $44,666	11,251 Added 5.24%	226,137 $461,000
Q4 2021 Feb 14, 2022	BUY	$2.4 - $5.01 $515,726 - $1.08 Million	214,886 New	214,886 $810,000

Ticker PETV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,072,000
Market Cap $5.04M
Description
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint affliction...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.